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Background: Practice guidelines for PCI were published by the ESC in 2005. Little is known about the current use of PCI for the different 
indications of ACS and stable angina in daily practice in Europe.
Methods: Between 2005 and 2008, 47,409 consecutive patients undergoing PCI were enrolled into the PCI-Registry of the Euro Heart Survey 
Programme (176 centres in 33 ESC countries) to document patient characteristics, PCI details and hospital complications in different PCI 
indications. We examined the impact of renal failure (RF: creatinine >2.0mg/dl / dialysis) on outcome in PCI for ACS and for stable angina.
Results: RF was present in 3.6% of patients undergoing PCI for ACS and in 3.2% of patients undergoing PCI for stable angina. Patients with RF were 
older and had a higher prevalence of concomitant diseases in both groups. Patients with ACS and RF had a significantly higher hospital mortality 
than patients without RF (OR 1.53; 95% CI 1.10-2.14). In patients undergoing PCI for stable angina, RF did not impact hospital mortality but stroke 
and bleeding complications (OR 2.59; 95% CI 1.51-4.44).
Conclusion: RF was an independent determinant for higher hospital mortality in patients undergoing PCI for ACS and for a higher incidence of 
stroke and major bleeding complications in PCI for stable angina. 
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p-value
Age [years] 73 64 <0.01 70 64 <0.01
Female Gender 28.2 % 26.5 % ns 24.4 % 24.9 % ns
Prior MI 46.4 % 25.7 % <0.01 45.0 % 41.0 % <0.05
Prior PCI 32.0 % 16.4 % <0.01 36.2 % 31.3 % <0.05
Diabetes mellitus 46.1 % 23.5 % <0.01 41.2 % 25.2 % <0.01
3-Vessel-Disease 44.5 % 23.8 % <0.01 31.9 % 17.6 % <0.01
Drug Eluting Stents 44.5 % 42.4 % ns 53.2 % 49.7 % <0.05
GP IIb/IIIa 21.4 % 32.3 % <0.01 11.3 % 16.9 % <0.01
LMW-Heparin 32.5 % 31.3 % ns 14.2 % 21.5 % <0.01
Hospital MI 2.0 % 2.1 % ns 1.8 % 0.7 % <0.01
Hospital Stroke 0.4 % 0.3 % ns 0.6 % 0.1 % <0.01
Major Bleeding 2.4 % 1.0 % <0.01 1.4 % 0.4 % <0.01
Hospital Mortality 5.7 % 2.2 % <0.01 0.5 % 0.2 % ns
